InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,319.31
(
2.30%
)
US TECH 100
18,006.00
(
3.54%
)
Dow Jones
39,446.49
(
1.76%
)
Brent Oil
78.94
(
0.25%
)
Bitcoin
60,975.52
(
-1.23%
)
Post# of 252816
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: DewDiligence post# 184155

Tuesday, 11/25/2014 12:31:54 PM

Tuesday, November 25, 2014 12:31:54 PM

Post# of 252816

Brad Loncar’s blog on FPRX (which you presumably concur with)

Absolutely. As a shareholder, I much prefer companies I'm invested in to sacrifice less short-term in cash to be involved with one of the leading companies in a given space rather than accepting more up-front to be paired with a second-tier player in a given space. BMY seems to be one of the key players in the immuno onc space. Besides, I view the $30M payment itself as very meaningful to FPRX.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up